GlaxoSmithKline Pharmaceuticals Ltd.

BSE: 500660 | NSE: GLAXO |

Represents Equity.Intra - day transactions are permissible and normal trading is done in this category

Series: EQ | ISIN: INE159A01016 | SECTOR: Pharmaceuticals & DrugsPharmaceuticals & Drugs

Success

Alert

Please select a Day.

Info

Open trading A/c Open trading A/c

GlaxoSmithKlin GlaxoSmithKline Pharmaceuticals Ltd. | BSE 2432.10 -19.70 (-0.80%) | NSE 2429.90 -24.00 (-0.98%) | Trade | Add

BSE Live

Apr 20, 16:01

2432.10 -19.70 (-0.80%)

Volume

AVERAGE VOLUME

5-Day

2,581

10-Day

2,322

30-Day

2,961

1,067

Prev. Close

2451.80
Open Price

2486.95

Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)

NSE Live

Apr 20, 15:57

2429.90 -24.00 (-0.98%)

Volume

AVERAGE VOLUME

5-Day

51,610

10-Day

54,011

30-Day

55,273

35,944

Prev. Close

2453.90
Open Price

2465.00

Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
2429.90 (261)

Financials

Print/Copy to Excel : Go

Balance Sheet of GlaxoSmithKline Pharmaceuticals (in Rs. Cr.)	Mar 25	Mar 24	Mar 23	Mar 22	Mar 21
	12 mths	12 mths	12 mths	12 mths	12 mths
EQUITIES AND LIABILITIES
SHAREHOLDER'S FUNDS
Equity Share Capital	169.41	169.41	169.41	169.41	169.41
Total Share Capital	169.41	169.41	169.41	169.41	169.41
Reserves and Surplus	1,781.90	1,617.24	1,573.54	2,493.55	1,308.85
Total Reserves and Surplus	1,781.90	1,617.24	1,573.54	2,493.55	1,308.85
Total Shareholders Funds	1,951.31	1,777.64	1,741.27	2,662.96	1,478.26
Minority Interest	0.00	0.00	0.00	0.00	0.00
NON-CURRENT LIABILITIES
Long Term Borrowings	0.00	0.00	0.00	0.00	0.00
Deferred Tax Liabilities [Net]	0.00	0.00	0.00	0.00	0.00
Other Long Term Liabilities	2.49	6.57	4.14	9.68	22.31
Long Term Provisions	249.11	247.46	254.80	262.21	259.50
Total Non-Current Liabilities	251.60	254.03	258.94	271.89	281.81
CURRENT LIABILITIES
Short Term Borrowings	0.00	0.00	0.00	0.00	0.02
Trade Payables	708.25	625.41	427.79	570.55	466.13
Other Current Liabilities	780.50	506.02	480.79	799.90	613.80
Short Term Provisions	416.41	393.52	417.79	327.98	274.62
Total Current Liabilities	1,905.15	1,524.95	1,326.37	1,698.43	1,354.58
Total Capital And Liabilities	4,108.07	3,556.62	3,326.58	4,633.28	3,114.65
ASSETS
NON-CURRENT ASSETS
Tangible Assets	270.32	297.72	295.87	296.15	343.55
Intangible Assets	13.33	23.55	34.09	34.50	43.36
Capital Work-In-Progress	14.32	13.93	20.31	30.50	13.21
Fixed Assets	297.97	335.20	350.27	361.15	400.12
Non-Current Investments	0.00	0.00	0.00	0.00	0.00
Deferred Tax Assets [Net]	140.87	146.31	133.55	113.15	103.13
Long Term Loans And Advances	0.00	0.00	70.00	190.00	0.00
Other Non-Current Assets	259.34	276.68	278.50	260.95	408.76
Total Non-Current Assets	698.18	758.20	832.32	925.25	912.01
CURRENT ASSETS
Current Investments	1,118.25	813.22	518.29	365.59	0.00
Inventories	481.74	525.05	459.97	534.70	546.70
Trade Receivables	292.55	222.06	192.38	205.24	215.60
Cash And Cash Equivalents	1,403.52	1,063.22	1,155.93	2,484.51	1,157.96
Short Term Loans And Advances	0.00	0.00	0.00	0.00	0.00
OtherCurrentAssets	113.83	174.87	167.70	118.00	282.37
Total Current Assets	3,409.88	2,798.42	2,494.26	3,708.03	2,202.64
Total Assets	4,108.07	3,556.62	3,326.58	4,633.28	3,114.65
OTHER ADDITIONAL INFORMATION
CONTINGENT LIABILITIES, COMMITMENTS
Contingent Liabilities	490.50	387.14	361.80	368.97	498.50
BONUS DETAILS
Bonus Equity Share Capital	125.39	125.39	125.39	125.39	125.39
NON-CURRENT INVESTMENTS
Non-Current Investments Quoted Market Value	0.00	0.00	0.00	0.00	0.00
Non-Current Investments Unquoted Book Value	0.00	0.00	0.00	0.00	0.00
CURRENT INVESTMENTS
Current Investments Quoted Market Value	0.00	0.00	0.00	0.00	0.00
Current Investments Unquoted Book Value	0.00	0.00	0.00	0.00	0.00